Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Ixabepilone, Carboplatin, and Trastuzumab in HER2-Positive Breast Cancer
NCT00821886Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Feb 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in HER2-positive breast cancer, sponsored by SCRI Development Innovations. Started Feb 2009; status: completed.
02
Drugs
ixabepilone
03
Conditions
HER2-positive breast cancer
Beyond the preview
Go deeper on NCT00821886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00821886.